Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
Pharmacology, Biochemistry, and Behavior|November 1, 1978
Effects of d-amphetamine and cocaine on repeated acquisition with timeout from avoidanceJ Schrot, J J Boren, J M Moerschbaecher, et al.Biochimica Et Biophysica Acta|April 30, 1992
Changes in phosphatidylethanolamine metabolism in regenerating rat liver as measured by 31P-NMRE J Murphy, K M Brindle, C J Rorison, et al.The Journal of Clinical Investigation|April 16, 1998
Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100J Boren, I Lee, W Zhu, et al.British Journal of Cancer|July 17, 1998
Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic statusD A Beauregard, P E Thelwall, D J Chaplin, et al.International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|August 24, 1999
The significance and mechanism of mitochondrial proton conductanceM D Brand, K M Brindle, J A Buckingham, et al.Biochemical and Biophysical Research Communications|February 29, 1988
31P NMR measurements of myocardial pH in vivoK M Brindle, B Rajagopalan, D S Williams, et al.International Journal of Oncology|September 20, 2001
Potent anti-metastatic activity of combretastatin-A4J Griggs, K M Brindle, J C Metcalfe, et al.Biochimica Et Biophysica Acta|October 19, 1992
Endoplasmic reticulum: the major contributor to the PDE peak in hepatic 31P-NMR spectra at low magnetic field strengthsE J Murphy, T E Bates, S R Williams, et al.British Journal of Cancer|March 22, 2001
Combretastatin-A4 disrupts neovascular development in non-neoplastic tissueJ Griggs, R Hesketh, G A Smith, et al.Neuroreport|March 15, 2000
Magnetic resonance imaging of transplanted oligodendrocyte precursors in the rat brainR J Franklin, K L Blaschuk, M C Bearchell, et al.Pageof 9